Curoverse
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.5m | Seed | ||
N/A | Early VC | ||
N/A | Early VC | ||
$100k | Grant | ||
N/A | Acquisition | ||
Total Funding | AUD2.5m |
Related Content
Recent News about Curoverse
EditCuroverse is a technology company specializing in open source software solutions for managing and processing large-scale biomedical data. The company operates in the healthcare and biotechnology sectors, serving bioinformaticians, IT teams, and clinical labs. Curoverse's core product, Arvados, is a modern open source computing system designed to handle terabytes to petabytes of data. It can be deployed on major cloud platforms or on-premise, providing flexibility and control over data management. The business model revolves around offering Arvados as a free, open source tool while generating revenue through premium support services, custom development, and consulting. By enabling efficient data analysis and management, Curoverse helps accelerate the transformation of biomedical research and precision medicine.
Keywords: open source, biomedical data, precision medicine, Arvados, cloud computing, data management, bioinformatics, IT solutions, clinical labs, healthcare technology.